U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923058) titled 'Clinical Trial of SEEG for Drug-resistant Epilepsy' on Oct. 21.
Brief Summary: This trial evaluates the safety and efficacy of SEEG recording and functional mapping for patients with drug-resistant epilepsy. It also assesses the safety and therapeutic effectiveness of SEEG-guided radiofrequency ablation for this patient group. The study will collect clinical evidence to support the standardized application of this combined diagnostic and treatment workflow for drug-resistant epilepsy.
Study Start Date: Oct. 23
Study Type: INTERVENTIONAL
Condition:
Drug-Resistant Epilepsy
Intervention:
PROCEDURE: SEEG RF-TC
The patient will und...